166 related articles for article (PubMed ID: 35142845)
1. Trans Fatty Acid Biomarkers and Incident Type 2 Diabetes: Pooled Analysis of 12 Prospective Cohort Studies in the Fatty Acids and Outcomes Research Consortium (FORCE).
Lai HTM; Imamura F; Korat AVA; Murphy RA; Tintle N; Bassett JK; Chen J; Kröger J; Chien KL; Senn M; Wood AC; Forouhi NG; Schulze MB; Harris WS; Vasan RS; Hu F; Giles GG; Hodge A; Djousse L; Brouwer IA; Qian F; Sun Q; Wu JHY; Marklund M; Lemaitre RN; Siscovick DS; Fretts AM; Shadyab AH; Manson JE; Howard BV; Robinson JG; Wallace RB; Wareham NJ; Chen YI; Rotter JI; Tsai MY; Micha R; Mozaffarian D;
Diabetes Care; 2022 Apr; 45(4):854-863. PubMed ID: 35142845
[TBL] [Abstract][Full Text] [Related]
2. Plasma Industrial and Ruminant Trans Fatty Acids and Incident Type 2 Diabetes in the EPIC-Potsdam Cohort.
Prada M; Wittenbecher C; Eichelmann F; Wernitz A; Kuxhaus O; Kröger J; Weikert C; Schulze MB
Diabetes Care; 2022 Apr; 45(4):845-853. PubMed ID: 35129607
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.
Imamura F; Fretts A; Marklund M; Ardisson Korat AV; Yang WS; Lankinen M; Qureshi W; Helmer C; Chen TA; Wong K; Bassett JK; Murphy R; Tintle N; Yu CI; Brouwer IA; Chien KL; Frazier-Wood AC; Del Gobbo LC; Djoussé L; Geleijnse JM; Giles GG; de Goede J; Gudnason V; Harris WS; Hodge A; Hu F; ; Koulman A; Laakso M; Lind L; Lin HJ; McKnight B; Rajaobelina K; Risérus U; Robinson JG; Samieri C; Siscovick DS; Soedamah-Muthu SS; Sotoodehnia N; Sun Q; Tsai MY; Uusitupa M; Wagenknecht LE; Wareham NJ; Wu JH; Micha R; Forouhi NG; Lemaitre RN; Mozaffarian D;
PLoS Med; 2018 Oct; 15(10):e1002670. PubMed ID: 30303968
[TBL] [Abstract][Full Text] [Related]
4. n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level Pooling Project of 20 Prospective Cohort Studies.
Qian F; Ardisson Korat AV; Imamura F; Marklund M; Tintle N; Virtanen JK; Zhou X; Bassett JK; Lai H; Hirakawa Y; Chien KL; Wood AC; Lankinen M; Murphy RA; Samieri C; Pertiwi K; de Mello VD; Guan W; Forouhi NG; Wareham N; Hu ICFB; Riserus U; Lind L; Harris WS; Shadyab AH; Robinson JG; Steffen LM; Hodge A; Giles GG; Ninomiya T; Uusitupa M; Tuomilehto J; Lindström J; Laakso M; Siscovick DS; Helmer C; Geleijnse JM; Wu JHY; Fretts A; Lemaitre RN; Micha R; Mozaffarian D; Sun Q;
Diabetes Care; 2021 May; 44(5):1133-1142. PubMed ID: 33658295
[TBL] [Abstract][Full Text] [Related]
5. Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.
Imamura F; Fretts AM; Marklund M; Ardisson Korat AV; Yang WS; Lankinen M; Qureshi W; Helmer C; Chen TA; Virtanen JK; Wong K; Bassett JK; Murphy R; Tintle N; Yu CI; Brouwer IA; Chien KL; Chen YY; Wood AC; Del Gobbo LC; Djousse L; Geleijnse JM; Giles GG; de Goede J; Gudnason V; Harris WS; Hodge A; Hu F; ; Koulman A; Laakso M; Lind L; Lin HJ; McKnight B; Rajaobelina K; Riserus U; Robinson JG; Samieri C; Senn M; Siscovick DS; Soedamah-Muthu SS; Sotoodehnia N; Sun Q; Tsai MY; Tuomainen TP; Uusitupa M; Wagenknecht LE; Wareham NJ; Wu JHY; Micha R; Lemaitre RN; Mozaffarian D; Forouhi NG
PLoS Med; 2020 Jun; 17(6):e1003102. PubMed ID: 32530938
[TBL] [Abstract][Full Text] [Related]
6. Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies.
Wu JHY; Marklund M; Imamura F; Tintle N; Ardisson Korat AV; de Goede J; Zhou X; Yang WS; de Oliveira Otto MC; Kröger J; Qureshi W; Virtanen JK; Bassett JK; Frazier-Wood AC; Lankinen M; Murphy RA; Rajaobelina K; Del Gobbo LC; Forouhi NG; Luben R; Khaw KT; Wareham N; Kalsbeek A; Veenstra J; Luo J; Hu FB; Lin HJ; Siscovick DS; Boeing H; Chen TA; Steffen B; Steffen LM; Hodge A; Eriksdottir G; Smith AV; Gudnason V; Harris TB; Brouwer IA; Berr C; Helmer C; Samieri C; Laakso M; Tsai MY; Giles GG; Nurmi T; Wagenknecht L; Schulze MB; Lemaitre RN; Chien KL; Soedamah-Muthu SS; Geleijnse JM; Sun Q; Harris WS; Lind L; Ärnlöv J; Riserus U; Micha R; Mozaffarian D;
Lancet Diabetes Endocrinol; 2017 Dec; 5(12):965-974. PubMed ID: 29032079
[TBL] [Abstract][Full Text] [Related]
7. Red blood cell membrane trans fatty acid levels and risk of non-Hodgkin lymphoma: a prospective nested case-control study.
Ardisson Korat AV; Chiu YH; Bertrand KA; Zhang S; Epstein MM; Rosner BA; Chiuve S; Campos H; Giovannucci EL; Chavarro JE; Birmann BM
Am J Clin Nutr; 2020 Dec; 112(6):1576-1583. PubMed ID: 33022699
[TBL] [Abstract][Full Text] [Related]
8. Genetic loci associated with circulating phospholipid trans fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium.
Mozaffarian D; Kabagambe EK; Johnson CO; Lemaitre RN; Manichaikul A; Sun Q; Foy M; Wang L; Wiener H; Irvin MR; Rich SS; Wu H; Jensen MK; Chasman DI; Chu AY; Fornage M; Steffen L; King IB; McKnight B; Psaty BM; Djoussé L; Chen IY; Wu JH; Siscovick DS; Ridker PM; Tsai MY; Rimm EB; Hu FB; Arnett DK
Am J Clin Nutr; 2015 Feb; 101(2):398-406. PubMed ID: 25646338
[TBL] [Abstract][Full Text] [Related]
9. Different Types of Industry-Produced and Ruminant Trans Fatty Acid Intake and Risk of Type 2 Diabetes: Findings From the NutriNet-Santé Prospective Cohort.
Wendeu-Foyet G; Bellicha A; Chajès V; Huybrechts I; Bard JM; Debras C; Srour B; Sellem L; Fezeu LK; Julia C; Kesse-Guyot E; Agaësse C; Druesne-Pecollo N; Galan P; Hercberg S; Deschasaux-Tanguy M; Touvier M
Diabetes Care; 2023 Feb; 46(2):321-330. PubMed ID: 36542554
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils.
Mozaffarian D; Clarke R
Eur J Clin Nutr; 2009 May; 63 Suppl 2():S22-33. PubMed ID: 19424216
[TBL] [Abstract][Full Text] [Related]
12. Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies.
Bendsen NT; Christensen R; Bartels EM; Astrup A
Eur J Clin Nutr; 2011 Jul; 65(7):773-83. PubMed ID: 21427742
[TBL] [Abstract][Full Text] [Related]
13. n-6 fatty acid biomarkers and incident atrial fibrillation: an individual participant-level pooled analysis of 11 international prospective studies.
Garg PK; Guan W; Nomura S; Weir NL; Tintle N; Virtanen JK; Hirakawa Y; Qian F; Sun Q; Rimm E; Lemaitre RN; Jensen PN; Heckbert SR; Imamura F; Steur M; Leander K; Laguzzi F; Voortman T; Ninomiya T; Mozaffarian D; Harris WS; Siscovick DS; Tsai MY;
Am J Clin Nutr; 2023 Nov; 118(5):921-929. PubMed ID: 37769813
[TBL] [Abstract][Full Text] [Related]
14. Circulating and dietary trans fatty acids and incident type 2 diabetes in older adults: the Cardiovascular Health Study.
Wang Q; Imamura F; Ma W; Wang M; Lemaitre RN; King IB; Song X; Biggs ML; Delaney JA; Mukamal KJ; Djousse L; Siscovick DS; Mozaffarian D
Diabetes Care; 2015 Jun; 38(6):1099-107. PubMed ID: 25784660
[TBL] [Abstract][Full Text] [Related]
15. Health effects of trans-fatty acids: experimental and observational evidence.
Mozaffarian D; Aro A; Willett WC
Eur J Clin Nutr; 2009 May; 63 Suppl 2():S5-21. PubMed ID: 19424218
[TBL] [Abstract][Full Text] [Related]
16. Trans-fatty acids and mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study.
Kleber ME; Delgado GE; Lorkowski S; März W; von Schacky C
Eur Heart J; 2016 Apr; 37(13):1072-8. PubMed ID: 26396230
[TBL] [Abstract][Full Text] [Related]
17. Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study.
Ma W; Wu JH; Wang Q; Lemaitre RN; Mukamal KJ; Djoussé L; King IB; Song X; Biggs ML; Delaney JA; Kizer JR; Siscovick DS; Mozaffarian D
Am J Clin Nutr; 2015 Jan; 101(1):153-63. PubMed ID: 25527759
[TBL] [Abstract][Full Text] [Related]
18. PUFA ω-3 and ω-6 biomarkers and sleep: a pooled analysis of cohort studies on behalf of the Fatty Acids and Outcomes Research Consortium (FORCE).
Murphy RA; Tintle N; Harris WS; Darvishian M; Marklund M; Virtanen JK; Hantunen S; de Mello VD; Tuomilehto J; Lindström J; Bolt MA; Brouwer IA; Wood AC; Senn M; Redline S; Tsai MY; Gudnason V; Eiriksdottir G; Lindberg E; Shadyab AH; Liu B; Carnethon M; Uusitupa M; Djousse L; Risérus U; Lind L; van Dam RM; Koh WP; Shi P; Siscovick D; Lemaitre RN; Mozaffarian D
Am J Clin Nutr; 2022 Mar; 115(3):864-876. PubMed ID: 34918026
[TBL] [Abstract][Full Text] [Related]
19. Intake of dietary saturated fatty acids and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition-Netherlands cohort: associations by types, sources of fatty acids and substitution by macronutrients.
Liu S; van der Schouw YT; Soedamah-Muthu SS; Spijkerman AMW; Sluijs I
Eur J Nutr; 2019 Apr; 58(3):1125-1136. PubMed ID: 29524001
[TBL] [Abstract][Full Text] [Related]
20. Trans-fatty Acids and Survival in Renal Transplantation.
Chandra A; Svensson M; Åsberg A; Schmidt EB; Bjerve KS; Jenssen T; Hartmann A; Ueland T; Eide IA
J Ren Nutr; 2019 May; 29(3):169-180. PubMed ID: 30309780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
